Targeted Clinical Trials for Antimicrobial Resistance
$5,696,248N01FY2015AINIH
Duke University, Durham NC
Investigators
Abstract
To evaluate strategies that test the safety and effectiveness of therapeutic approaches/regimens to reduce the probability of the emergence of antibiotic drug resistance by minimizing unnecessary drug exposure. Trial title: A Multi-Center, Randomized, Open-Label, Comparative Study to Assess the Safety and Efficacy of a Treatment Algorithm to Reduce the Use of Vancomycin in Adult Patients With Blood Stream Infections Due to Staphylococci.
View original record on NIH RePORTER →